Frontiers in Pharmacology | Pharmacoepidemiology

Systematic Review

Published on 30 Sep 2022

Comparison of dexmedetomidine and remifentanil on reducing coughing during emergence from anesthesia with tracheal intubation: A meta-analysis

in Pharmacoepidemiology

Xing Fan
Hai Cai
Bingbing Pan
Yubo Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993239

2,742 views
3 citations

Original Research

Published on 28 Sep 2022

Medically assisted reproduction and the risk of being born small and very small for gestational age: Assessing prematurity status as an effect modifier

in Pharmacoepidemiology

Jessica Gorgui
Odile Sheehy
Jacquetta Trasler
Anick Bérard

Frontiers in Pharmacology

doi 10.3389/fphar.2022.904885

2,034 views
1 citation

Original Research

Published on 27 Sep 2022

Prescription medication use of United States military service members by therapeutic classification

in Pharmacoepidemiology

Joseph J. Knapik
Daniel W. Trone
Ryan A. Steelman
Emily K. Farina
Harris R. Lieberman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.972031

7,002 views
3 citations

Original Research

Published on 26 Sep 2022

Association between antibiotics and dementia risk: A retrospective cohort study

in Pharmacoepidemiology

Minseo Kim
Sun Jae Park
Seulggie Choi
Jooyoung Chang
Sung Min Kim
Seogsong Jeong
Young Jun Park
Gyeongsil Lee
Joung Sik Son
Joseph C. Ahn

Frontiers in Pharmacology

doi 10.3389/fphar.2022.888333

10,885 views
28 citations

Original Research

Published on 20 Sep 2022

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

in Pharmacoepidemiology

Luiza Hoehl Loureiro Alves Barbosa
Alice Ramos Oliveira Silva
Ana Paula D’Alincourt Carvalho-Assef
Elisangela Costa Lima
Fabricio Alves Barbosa da Silva

Frontiers in Pharmacology

doi 10.3389/fphar.2022.948339

3,841 views
2 citations

Original Research

Published on 16 Sep 2022

Role of daytime variation in pharmaceutical effects of sufentanil, dezocine, and tramadol: A matched observational study

in Pharmacoepidemiology

Wanxia Gan
Xinqing Yang
Jie Chen
Hongyao Lyu
Ai Yan
Guizhen Chen
Shiqi Li
Yamei Zhang
Ling Dan
He Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993506

2,353 views
1 citation

Original Research

Published on 15 Sep 2022

An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project

in Pharmacoepidemiology

Valeria Belleudi
Alessandro C. Rosa
Marco Finocchietti
Francesca R. Poggi
Maria Lucia Marino
Marco Massari
Stefania Spila Alegiani
Lucia Masiero
Andrea Ricci
Gaia Bedeschi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.959267

2,905 views
13 citations

Original Research

Published on 14 Sep 2022

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients

in Pharmacoepidemiology

Akihiko Nishimura
Junqing Xie
Kristin Kostka
Talita Duarte-Salles
Sergio Fernández Bertolín
María Aragón
Clair Blacketer
Azza Shoaibi
Scott L. DuVall
Kristine Lynch

Frontiers in Pharmacology

doi 10.3389/fphar.2022.945592

3,388 views
4 citations

Original Research

Published on 13 Sep 2022

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease

in Pharmacoepidemiology

Yong-Li Gu
Zeng-Xian Sun
Ying Sun
Yan Wen
Xin Guan
Dao-Li Jiang
Cong Cheng
Huan Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.892526

2,341 views
1 citation

Original Research

Published on 13 Sep 2022

Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study

in Pharmacoepidemiology

Yen-Chieh Lee
Yaa-Hui Dong
Wei-Shun Yang
Li-Chiu Wu
Jou-Wei Lin
Chia-Hsuin Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.869804

2,723 views
2 citations

Original Research

Published on 07 Sep 2022

Trends in the utilization of psychotropic medications in China from 2018 to 2021

in Pharmacoepidemiology

Xinyan Zhang
Xiaowen Hu
Yuxuan Zhao
Christine Y. Lu
Xiaoyan Nie
Luwen Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967826

3,947 views
11 citations

Original Research

Published on 06 Sep 2022

Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database

in Pharmacoepidemiology

Yamin Shu
Qilin Zhang
Xucheng He
Yanxin Liu
Pan Wu
Li Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.990241

34,581 views
33 citations

Original Research

Published on 06 Sep 2022

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed

in Pharmacoepidemiology

Kristjan Linnet
Heidrun Sjofn Thorsteinsdottir
Johann Agust Sigurdsson
Emil Larus Sigurdsson
Larus Steinthor Gudmundsson

Frontiers in Pharmacology

doi 10.3389/fphar.2022.932380

2,746 views
3 citations

Clinical Trial

Published on 05 Sep 2022

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale

in Pharmacoepidemiology

Nicolas Kerckhove
Noémie Delage
Célian Bertin
Emmanuelle Kuhn
Nathalie Cantagrel
Caroline Vigneau
Jessica Delorme
Céline Lambert
Bruno Pereira
Chouki Chenaf

Frontiers in Pharmacology

doi 10.3389/fphar.2022.947006

3,156 views
7 citations

Review

Published on 25 Aug 2022

Immune-related adverse events of biological immunotherapies used in COVID-19

in Pharmacoepidemiology

Daniela Baracaldo-Santamaría
Giovanna María Barros-Arias
Felipe Hernández-Guerrero
Alejandra De-La-Torre
Carlos-Alberto Calderon-Ospina

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973246

3,385 views
3 citations

Methods

Published on 23 Aug 2022

Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data

in Pharmacoepidemiology

Odile Sauzet
Victoria Cornelius

Frontiers in Pharmacology

doi 10.3389/fphar.2022.889088

1,908 views
7 citations

Navigation group

Articles

Comparison of dexmedetomidine and remifentanil on reducing coughing during emergence from anesthesia with tracheal intubation: A meta-analysis

Medically assisted reproduction and the risk of being born small and very small for gestational age: Assessing prematurity status as an effect modifier

Prescription medication use of United States military service members by therapeutic classification

Association between antibiotics and dementia risk: A retrospective cohort study

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

Role of daytime variation in pharmaceutical effects of sufentanil, dezocine, and tramadol: A matched observational study

An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease

Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study

Trends in the utilization of psychotropic medications in China from 2018 to 2021

Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale

Immune-related adverse events of biological immunotherapies used in COVID-19

Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data